NEW YORK (GenomeWeb News) – Investment bank Thomas Weisel Partners has initiated coverage of Waters with an "overweight" rating on the firm's stock.

Analyst Peter Lawson wrote in a research note Thursday that Waters received an "overweight" rating because of three factors: its "industry-leading position in the life science space with industry high operating margins; its better-than-peer execution on earnings growth, organic revenue growth, and earnings consistency; and its discount valuation versus both peers and historical levels."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.